According to RVL Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is S$50.02 Million. In 2022 the company made a revenue of S$66.65 Million an increase over the revenue in the year 2021 that were of S$54.67 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.